Pharmaceutical 99% Powder Trimebutine For Antispasmodic CAS 39133-31-8 CAS NO.39133-31-8

Pharmaceutical 99% Powder Trimebutine For Antispasmodic CAS 39133-31-8

 

Quick Detail:

Product Name	Trimebutine
Alias	Trimebutin;Trimebutine hydrochloride;3,4,5-Trimethoxybenzoic acid 2-(dimethylamino)-2-phenylbutyl ester
CAS	39133-31-8
MF	C22H29NO5
MW	387.47
EINECS	254-309-2
Purity	99%
Appearance	White Powder
Melting Point	78-80°C
Certification	ISO 9001, USP, BP
Standard	Enterprise standard
Usage	Opioid receptor agonist. Antispasmodic.
Packing	Discreet packing ways as your requirement, 100% go through
Storage	Store in cool and dry area and keep away from direct sunlight

 

Description:

 

Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects. The maleic acid salt of trimebutine is marketed under the trademark of Debridat, Recutin, Polybutin,or Modulon for treatment of irritable bowel syndrome and other gastrointestinal disorders. The major product from drug metabolism of trimebutine in human beings is nortrimebutine,which comes from removal of one of the methyl groups attached to nitrogen.Trimebutine exerts its effects in part due to causing a premature activation of phase III of the migrating motor complex in the digestive tract.Both Trimebutine and its metabolite are commercially available.

 

Ranitidine, is a medication that decreases stomach acid production.It is commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. There is also tentative evidence of benefit for hives. It can be taken by mouth, by injection into a muscle, or into a vein.

 

Common side effects include headaches and pain or burning if given by injection. Serious side effects may include liver problems, a slow heart rate, pneumonia, and the potential of masking stomach cancer. It is also linked to an increased risk of Clostridium difficile colitis. It is generally safe in pregnancy. Ranitidine is an H2 histamine receptor antagonist that works by blocking histamine and thus decreasing the amount of acid released by cells of the stomach.